BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • May 18th, 2020 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 18th, 2020 Company Industry JurisdictionBoston Scientific Corporation (the “Company”) proposes to issue and sell its Debt Securities having an aggregate principal amount of U.S. $1,700,000,000 or the equivalent thereof in foreign currencies or currency units (the “Securities”). The Securities will be issued under an indenture dated as of May 29, 2013 between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented from time to time by supplemental indentures and/or modified from time to time by resolutions of the Board of Directors of the Company, Pricing Certificate of Authorized Officers thereof or Officer’s Certificate as provided in Section 301 of such indenture (such indenture as so supplemented and/or modified being hereinafter referred to as the “Indenture”).
BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • November 12th, 2019 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 12th, 2019 Company Industry JurisdictionBoston Scientific Corporation (the “Company”) proposes to issue and sell its Debt Securities having an aggregate principal amount of €900,000,000 (the “Securities”). The Securities will be issued under an indenture dated as of May 29, 2013 between the Company and U.S. Bank National Association, as trustee (the “Trustee”), as supplemented from time to time by supplemental indentures and/or modified from time to time by resolutions of the Board of Directors of the Company, Pricing Certificate of Authorized Officers thereof or Officer’s Certificate as provided in Section 301 of such indenture (such indenture as so supplemented and/or modified being hereinafter referred to as the “Indenture”).
BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • February 25th, 2019 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 25th, 2019 Company Industry Jurisdiction
BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • February 26th, 2018 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 26th, 2018 Company Industry Jurisdiction(ii)the Company is duly qualified to do business as a foreign corporation and is in good standing under the laws of each jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not have a Material Adverse Effect;
BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • May 12th, 2015 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 12th, 2015 Company Industry Jurisdiction
BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • August 13th, 2013 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledAugust 13th, 2013 Company Industry Jurisdiction
BOSTON SCIENTIFIC CORPORATION Debt Securities UNDERWRITING AGREEMENT-BASIC PROVISIONSUnderwriting Agreement • November 17th, 2005 • Boston Scientific Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledNovember 17th, 2005 Company Industry JurisdictionBoston Scientific Corporation (the “Company”) proposes to issue and sell its Debt Securities having an aggregate initial public offering price or purchase price of up to U.S. $750,000,000 or the equivalent thereof in foreign currencies or currency units (the “Securities”). The Securities will be issued under an indenture dated November 18, 2004 between the Company and J.P. Morgan Trust Company, National Association, as trustee (the “Trustee”), as supplemented from time to time by supplemental indentures and/or modified from time to time by resolutions of the Board of Directors of the Company as provided in Section 301 of such indenture (such indenture as so supplemented and/or modified being hereinafter referred to as the “Indenture”).